"Retina Vitreous Associates is a leading vitreoretinal surgical practice and ophthalmology clinic in Ohio, with eight office locations. We are comprised of six board-certified, full-time vitreoretinal surgeons specializing in both medical and surgical retinal disorders. Retina Vitreous Associates was founded in 1974 and is one of the longest established and largest subspecialty groups of its kind in the nation."

During the past decade, Retina Vitreous Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retina Vitreous Associates" #1 collaborator was "QLT Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Retina Vitreous Associates" are "Age Related Macular Degeneration" (1 trials) and "Macular Degeneration" (1 trials). Many other conditions were trialed in "Retina Vitreous Associates" in a lesser frequency.

Most popular intervention types in "Retina Vitreous Associates" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ranibizumab" (1 trials), "ranibizumab, dexamethasone and verteporfin" (1 trials) and "rhuFab V2 (ranibizumab)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Retina Vitreous Associates" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Retina Vitreous Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Retina Vitreous Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Retina Vitreous Associates, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".